EIF5A2 and hepatocellular carcinoma: For example, N1-guanyl-1,7-diaminoheptane (GC7), an inhibitor of eIF5A2, reduced doxorubicin resistance in hepatocellular carcinoma cells by reversing hypoxia-induced EMT through the HIF-1α signaling pathway [33].